Optava Unit Dose
Optava Unit Dose is a medicine authorised by Swissmedic under authorisation number 62363. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 20 December 2011 and the authorisation is valid without a time limit. ATC code S01XA20 places the medicine in the group Ophthalmologicals.
| Authorisation number | 62363 |
|---|---|
| Name | Optava Unit Dose |
| Full name | Optava Unit Dose, Augentropfen |
| Authorisation holder | AbbVie AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | S01XA20 |
| First authorisation | 20 December 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Optava Unit Dose, Augentropfen | D | 20 December 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 30 x 0,4 ml | Einzeldose(n) | S01XA20 | 11.08.2. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Optava Unit Dose authorised in Switzerland?
Yes. Optava Unit Dose is authorised by Swissmedic under authorisation number 62363, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Optava Unit Dose have?
Optava Unit Dose is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Optava Unit Dose?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.